Strategic Advisory Board
We are supported by international experts and key opinion leaders to help guide our scientific strategy and build academic networks to enable access to cutting-edge research from world-renowned laboratories to strengthen our drug discovery programs.
Professor Roger Reddel
Chair of the SAB
Prof. Roger Reddel, BSc (Med), MBBS, FRACP, PhD, FAAHMS, FAA is Director of Children’s Medical Research Institute (CMRI) and the Sir Lorimer Dods Professor, Faculty of Medicine and Health, University of Sydney.
Prof. Reddel is the discoverer of the Alternative Lengthening of Telomeres (ALT) mechanism in human cancers, which is addressed by Tessellate Bio’s program, and a co-inventor of the ALT-specific companion diagnostic tool, the c-circle assay which Tessellate Bio is co-developing as a companion diagnostic.
Professor Hilda Pickett
Prof. Hilda Pickett, PhD is a co-founder of Tesselate Bio and is Head of the Telomere Length Regulation Unit at Children’s Medical Research Institute (CMRI), and Conjoint Professor at the University of Sydney.
Professor Claus Azzalin
Prof. Claus Azzalin, PhD is a co-founder of Tesselate Bio and group leader at Instituto de Medicina Molecular (iMM), Lisbon, and a Professor at the University of Lisbon, Portugal.
Professor René Bernards
Prof. René Bernards, PhD is Group Leader at the Netherlands Cancer Institute (NKI), Amsterdam and Professor of Molecular Carcinogenesis at Utrecht University, The Netherlands.
Associate Professor Andrew Deans
Andrew Deans, PhD is Associate Professor and Head of the Genome Stability Unit at St. Vincent’s Institute for Medical Research (SVI) in Melbourne, Australia.
Professor Christopher Lord
Prof. Christopher Lord, DPhil is Deputy Head of Division, Deputy Director of the Breast Cancer Now Toby Robins Research Centre, Group Leader of the CRUK Gene Function Laboratory and Professor of Cancer Genomics at the Institute of Cancer Research (ICR), London, United Kingdom.
Professor George Demetri
Prof. George D. Demetri, MD is a Professor of Medicine at Harvard Medical School, Director at the Center for Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute (DFCI), and Quick Family Chair, Medical Oncology at the DFCI in Boston, United States.
Professor Giulio Draetta
Prof. Giulio Draetta, MD PhD is Chief Scientific Officer, Sewell Family Distinguished University Chair and Professor of Genomic Medicine at the University of Texas MD Anderson Cancer Center.
Professor Timothy Yap
Prof. Timothy Yap MD PhD FRCP is Professor in the Department for Investigational Cancer Therapeutics and the Department of Thoracic/Head and Neck Medical Oncology, as well as Vice President, Head of Clinical Development in the Therapeutics Discovery Division and Associate Director of Translational Research in the Institute for Personalized Cancer Therapy.
Professor Sandra Strauss
Prof. Sandra Strauss, MBBS FRCP PhD is a Professor of Medical and Teenage Young Adult Cancer (TYA) and an honorary consultant medical oncologist at University College London Hospital NHS Trust.
© Tessellate Bio
